v3.26.1
Financing Agreements
12 Months Ended
Jun. 30, 2026
Debt Disclosure [Abstract]  
Financing Agreements

15. FINANCING AGREEMENTS

Lines of Credit - Trading Credit Facility

On December 21, 2021, the Company entered into a three-year committed facility provided by a syndicate of financial institutions (the “Trading Credit Facility”), with a total revolving commitment of up to $350.0 million and with a termination date of December 21, 2024. As of June 30, 2026, the Trading Credit Facility has since been amended and restated to modify certain terms and conditions, including eliminating provisions whereby lenders under certain conditions could require repayment of all obligations outstanding under the Trading Credit Facility within 10 days on demand, extending the maturity date to September 30, 2027, and revising the total facility to $427.5 million. There is also an incremental revolving loan feature that is available under certain conditions up to an aggregate additional $73.0 million.

The Trading Credit Facility is secured by substantially all of the Company’s assets on a first priority basis and is guaranteed by the Company's subsidiaries. The Trading Credit Facility currently bears interest at the daily SOFR rate plus an applicable margin of 236 basis points. As of June 30, 2026, the interest rate on our Trading Credit Facility was approximately 6.1% and the daily SOFR rate was approximately 3.7%.

When needed, we use funds drawn under the Trading Credit Facility to purchase metals from our suppliers and for operating cash flow purposes. Our CFC subsidiary also uses funds drawn under the Trading Credit Facility to finance certain of its lending activities.

Borrowings totaled $0.0 million and $345.0 million at June 30, 2026 and June 30, 2025, respectively. The amounts available under the respective lines of credit are determined at the end of each week and at each month end following a specified borrowing base formula. The Company is able to access additional credit as needed to finance operations, subject to the overall limits of the borrowing facilities and lender approval of the borrowing base calculation. Based on the month end borrowing bases in effect, the availability under the Trading Credit Facility, after taking into account current borrowings, totaled $427.5 million and $99.1 million as determined on June 30, 2026 and June 30, 2025, respectively. As of June 30, 2026 and June 30, 2025, the remaining unamortized balance of loan costs was approximately $1.9 million and $3.5 million, respectively.

The Trading Credit Facility contains various covenants, all of which the Company was in compliance with as of June 30, 2026.

Interest expense related to the Company’s Trading Credit Facility totaled $21.2 million, $26.6 million, and $24.3 million, which represents 34.7%, 57.5%, and 61.4% of the total interest expense recognized for the years ended June 30, 2026, 2025, and 2024, respectively. The Trading Credit Facility carried a daily weighted-average effective interest rate of 8.4%, 8.7%, and 8.5% for the years ended June 30, 2026, 2025, and 2024, respectively.

Leaseback Financing Obligation

As part of the acquisition of AMS in April 2025, the Company assumed a leaseback financing obligation related to AMS's offices in Eagan, Minnesota. The original transaction, entered into by AMS in August 2024, involved the sale of the property followed by a leaseback arrangement. Due to certain economic terms of the lease, the transaction did not qualify for sale-leaseback accounting. Under a failed sale-leaseback arrangement, the property is accounted for as property, plant, and equipment, and the lease is accounted for as a financing obligation.

The carrying amount of the leaseback financing obligation as of June 30, 2026 was $7.5 million, with a remaining term of 13 years and an effective interest rate of 8.6%. The obligation is secured by the underlying property, which had a net book value of $7.6 million as of June 30, 2026. Future minimum payments under the arrangement are as follows (in thousands):

Fiscal Year ending June 30,

 

Financing Payments (Undiscounted)

 

 

2027

 

$

768

 

 

2028

 

 

787

 

 

2029

 

 

807

 

 

2030

 

 

827

 

 

2031

 

 

848

 

 

Thereafter

 

 

7,764

 

 

Total future payments

 

 

11,801

 

 

Imputed interest

 

 

(6,089

)

 

Present value (1)

 

$

5,712

 

 

 

(1)
The difference between the carrying amount of the leaseback financing obligation and the present value of the financing payments reflects the difference between the total contractual payments required under the leaseback arrangement and the fair value of the financing obligations assumed at the acquisition date.

The Company has recorded the current portion of this obligation within accrued liabilities and the noncurrent portion within other liabilities in its consolidated balance sheet, with related interest expense recognized in the consolidated statement of operations. The total interest expense incurred during the years ended June 30, 2026 and 2025 was $0.6 million and $0.2 million, respectively.

Notes Payable — Related Party

See Note 14.

Liabilities on Borrowed Metals and Precious Metals Leases

Liabilities on Borrowed Metals

Liabilities may also arise from: (i) metal positions held by customers in the Company’s inventory, (ii) amounts due to suppliers for the use of their consigned inventory, and (iii) shortages in unallocated metal positions held by the Company in the supplier’s inventory, and (iv) advanced pool metals borrowed under short-term agreements using other precious metals from its inventory as collateral. Unallocated or pool metal represents an unsegregated inventory position that is due on demand, in a specified physical form, based on the total ounces of metal held in the position. Amounts due under these arrangements require delivery either in the form of precious metals or in cash.

The Company recorded liabilities on borrowed metals with market values totaling $776.1 million and $46.1 million as of June 30, 2026 and June 30, 2025, respectively, which were included in inventories on the consolidated balance sheet.

Precious Metals Leases

The Company leases precious metals from its suppliers and customers under short-term arrangements, in which the lease terms and interest rates are established at lease inception. The Company has the ability to sell the metals advanced. These arrangements can be settled by repayment in similar metals or in cash.

Precious metals leases of $1.688 billion and $246.5 million as of June 30, 2026 and 2025, respectively, were included in deferred revenue and other advances on the consolidated balance sheet.

For the years ended June 30, 2026, 2025, and 2024, the interest expense related to liabilities on borrowed metals and precious metals leases totaled $16.2 million, $5.2 million, and $2.0 million, which represents 26.5%, 11.2%, and 5.0% of the total interest expense recognized by the Company, respectively. The weighted-average effective interest rate related to liabilities on borrowed metals and precious metals leases was 2.2%, 3.4%, and 2.9% for the years ended June 30, 2026, 2025, and 2024, respectively.

Product Financing Arrangements

The Company has agreements with third-party financial institutions which allow the Company to transfer its gold and silver inventory at an agreed-upon price, which is based on the spot price. Such agreements allow the Company to repurchase this inventory upon demand at an agreed-upon price based on the spot price on the repurchase date. The third-party charges a monthly fee as a percentage of the market value of the outstanding obligation; such monthly charges are classified in interest expense. These transactions do not qualify as sales, and therefore have been accounted for as financing arrangements and are reflected in the consolidated balance sheet as product financing arrangements. The obligation is stated at the amount required to repurchase the outstanding inventory. Both the product financing obligation and the underlying inventory (which is entirely restricted) are carried at fair value, with changes in fair value recorded as a component of cost of sales in the consolidated statements of income. Such obligations totaled $89.2 million and $484.7 million as of June 30, 2026 and June 30, 2025, respectively.

For the years ended June 30, 2026, 2025, and 2024, the interest expense related to product financing arrangements totaled $21.5 million, $13.6 million, and $9.9 million, which represents 35.2%, 29.3%, and 25.0% of the total interest expense recognized by the Company, respectively.